“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."
Ovarian Cancer
Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.
Ovarian cysts are very common in women with regular periods. In fact, most women won’t even be aware that they have a cyst unless there is a problem that causes the cyst to grow or if multiple cysts form. But do ovarian cysts increase cancer risk or cause infertility? Dr. Frederick explains.
Most stories about cancer don’t begin with the word “luck.” But mine does.
While an estimated 5 to 10 percent of all cancers are due to hereditary factors, ovarian cancer is unique—up to 25 percent of these cancers are thought to have a hereditary cause.
Growing up as the daughter of two physicians in Budapest, Hungary, Emese Zsiros, MD, PhD, FACOG, recognized her passion for medicine at an early age. She earned a combined MD/PhD at one of the top medical schools in Europe before heading to the United States to complete her OB/GYN residency.
The U.S. Supreme Court's unanimous ruling — that companies may no longer patent human genes — resonated across the cancer community, resulting in promising news for cancer patients and researchers.
Borderline ovarian tumors represent a small subset of epithelial ovarian tumors. Because it’s an uncommon and unfamiliar diagnosis, it’s often misunderstood.